SUMO1 and hepatocellular carcinoma: SUMO-1-modified CPAP enhances the transcriptional activity of NF-κB in HCC cells [31]; overexpressed CPAP directly interacts with STAT3 to enhance IL-6-mediated STAT3 activation and promote HCC tumor growth and metastasis [29].